Sex-related differences in stroke outcome at The University of Maiduguri Teaching Hospital, Northeastern Nigeria by Musa, WM et al.
African Journal of Neurological Sciences     2012 - Vol. 31, No 2 
http://ajns.paans.org 
8 
CLINICAL STUDIES / ETUDE CLINIQUES 
SEX-RELATED DIFFERENCES IN STROKE OUTCOME AT THE UNIVERSITY OF MAIDUGURI TEACHING 
HOSPITAL, NORTHEASTERN NIGERIA 
MUSA Watila M. 
1
 






DANJUMMAI Gezawa Ibrahim 
1
 
ANGAYA Sunday Bwala 
1
 
1. University of Maiduguri Teaching hospital, Maiduguri, Borno State. Nigeria 
E-Mail Contact - MUSA Watila M. : watilamusa (at) yahoo (dot) com  




Studies have reported sex differences in stroke risk factor, presentation, morbidity and mortality. This study aims to 
determine the effect of sex on morbidity and 30-day fatality in patients with acute stroke. 
Methods: 
Ninety-one patients were recruited for the study. We documented sex differences in stroke presentation, stroke 
severity on admission and discharge, and 30-day in-hospital fatality. Continuous variables were assessed using the 
student t-test. While outcome measures were analysed using the logistic regression analysis. Results: There were 
61 men (67%) and 30 women (33%) seen during the study period. Women were less likely to be formally educated 
(P = 0.024). Men were more likely to have lacunar strokes (P = 0.048), to smoke (P = 0.046) and take alcohol (P = 
0.027). Men had a higher diastolic blood pressure at presentation (P = 0.046), even though they were more likely to 
be on antihypertensive medications pre-stroke (P = 0.036). Women were more likely to present with coma on 
presentation (P = 0.003), and suffer urinary tract infections (P = 0.023). Women were also more likely to have a 
severe stroke on admission (Barthel’s ADL < 45, odds ratio OR = 5.30; 95% CI, 1.10 to 25.62 and mRS > 4, OR = 
5.38; 95% CI, 1.53 to 18.96) and a poorer activity of daily living (ADL) status on discharge (OR = 4.40; 95% CI, 1.45 
to 13.35). 
Conclusions: 
Sex differences in outcome exist in this study and women appear to have a poorer stroke outcome, more studies are 
needed to assess sex differences in response to therapy. 
 
INTRODUCTION 
Stroke is a leading cause of long-term disability, (1) and the second most common cause of death worldwide, 
accounting for about 8% of total deaths in developing countries. (5) 
Men have a higher incidence of stroke, but women appear to have more severe strokes and a higher case 
fatality. (3) This has lead to an increasing concern for women with stroke with the ‘Go red for women’ 
campaign, due to the increasing burden and uniqueness of stroke in women. (37, 8, 45, 13, 24, 10) 
Studies have reported sex-specific differences in stroke aetiology (37, 13, 24), presentations (45, 26, 44), 
diagnosis (39, 34, 47), treatments (13, 39, 36, 22) and outcomes (8, 13, 43, 19, 12). 
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Reports have shown that women hospitalized for stroke were less likely to be investigated (34, 47), have a 
carotid endarterectomy (34), or receive thrombolytic therapy. (13, 36, 40) While some studies are in 
agreement that women have more severe strokes and a lower quality of life than men (39, 43, 24, 38), others 
are in disagreement. (19, 17, 35) 
Studies on sex difference in stroke mortality have been variable, some studies reported a higher mortality in 
women (24, 38, 4, 11), others reported a higher mortality in men (16, 42) and other studies reported no 
significant sex difference in stroke mortality (8, 19). These varying differences in mortality may be due to 
patient’s characteristics and how stroke and mortality are defined. (42) 
Reasons proposed for poorer outcomes in women include, older age and comorbidities; (24, 11) differences 
in acute stroke management; (8, 13, 34) and poorer functional recovery at rehabilitation. (33) Experimental 
studies are postulating cellular and pathophysiological basis for these sex differences, (25, 27) which is a 
subject for further researches. 
Based on the above observation we sought to determine sex differences in stroke morbidity and mortality, as 
such differences may provide an opportunity for improved patient care. 
MATERIALS AND METHODS 
The study cohort was 91 stroke patients admitted through the accident and emergency unit or the neurology 
clinic of the University of Maiduguri Teaching Hospital (UMTH), North-eastern Nigeria. Stroke was clinically 
defined by the WHO criteria as rapidly developing clinical sign of focal and/or global disturbance of cerebral 
function, with symptoms lasting twenty-four hours or longer or leading to death with no apparent cause other 
than of vascular origin. (50) 
During the five year period (2005-2009), two hundred and eighty-five (285) suspected stroke patients were 
attended to; one hundred and ninety-four patients were excluded from the study. Those excluded from the 
study were patients who had no computerized tomography (CT) or magnetic resonance (MRI) scan of the 
brain, those with a diagnosis of subarachnoid haemorrhage, subdural haematoma, those who died within 
24hrs of admission and those with a past history of stroke. (Figure 1) All patients had an oral or written 
consent; consent was interpreted to some subjects into the local dialect for better understanding. History and 
examination was conducted and documented in the UMTH stroke proforma which included age and 
educational level. Risk factors for stroke such as hypertension (current blood pressure values 140/95 mmHg 
or features of long standing hypertension), atrial fibrillation (AF) (electrocardiographic evidence), transient 
ischaemic attack (TIA), diabetes mellitus (DM), smoking, alcohol consumption and a diagnosis of Human 
immunodeficiency virus (HIV) infection were recorded, this has been stated in an earlier study. (48) 
Medications taken by the patients before the stroke were also noted. Level of consciousness evaluated by 
the Glasgow Coma Score (a GCS < 8 is taken as coma). The distinction between ischaemic and 
haemorrhagic stroke was determined by CT or MRI. Patients with ischaemic stroke were categorized into; 
Total anterior circulation stroke (TACS), Partial anterior circulation stroke (PACS), Posterior circulation stroke 
(POCS) and Lacunar stroke. 
Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS). Disability and 
handicap were rated using the modified Rankin scale (mRS) and the Barthel ADL index (BI). These 
measures were also assessed at the time of discharge as outcome measures. The mRS identifies at a 
glance stroke disability, the BI assesses activity of daily living, but weighs heavily on motor functions, while 
the NIHSS provide the most prognostic information. (29) 
Duration of hospital stay was recorded only for those who survived till time of discharge. Death within 30 
days attributable to the stroke was recorded from date of stroke admission. All the above data were 
categorized based on sex. 
Statistical Analysis  
Student’s t-test and the Z-test were used to assess continuous variables. The BI and the mRS were 
dichotomized for logistic regression analysis. The selected categories were severe stroke on admission (BI < 
45 and mRS > 4), Poor ADL Status on discharge (BI < 45), independent on discharge (mRS <1 and BI > 90), 
and 30-day fatality was evaluated in a logistic regression analyses, controlling for age and clinical variables, 
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these results were expressed as odds ratios (ORs). All statistical data were analyzed using SPSS (version 
16.1) software. 
RESULTS 
During the five year period 285 patients had a diagnosis of suspected stroke, 194 patients were excluded 
from the study as shown in Figure 1. Ninety-one patients were registered for the study. All recruited patients 
were blacks residing in Nigeria. There were 61 men (67%) and 30 women (33%), mean age of 56.2 +11.1 
and 55.6 + 12.4 years in men and women respectively. Compared to men, women were less likely to be 
formally educated (P = 0.024). 
Table 1 shows stroke subtypes. There was no statistical difference in stroke subtype; as 25 (83.3%) women 
compared with 48 (78.7%) men had CT evidence of infarction (P=0.812), while 5 (16.7%) women compared 
with 13 (21.3%) had haemorrhagic stroke (P = 0.812). Lacunar stroke was more common in men (P = 
0.048), with no significant difference in other syndromes of ischaemic stroke. 
Men were more likely to take alcohol (P = 0.027) and to smoke (P = 0.046). There was no significant sex 
difference in other risk factors when comparing history of hypertension, DM, TIA, AF, HIV infection. Men 
were more likely to be treated with antihypertensives compared with women (P = 0.036) There was no 
significant difference in the use of diabetic, antiplatelet and lipid-lowering medications (Table 1). . The clinical 
state at the time of presentation showed that women were more likely to be in coma compared to men (P = 
0.003). Men were more likely to have a higher diastolic pressure at presentation (P = 0.047). There was no 
mean difference in random blood sugar (P = 0.772). 
From the logistic regression in Table 2, women were about five times more likely to have severe stroke on 
admission (BI < 45, OR = 5.30; 95% CI, 1.10 to 25.62 and mRS > 4, OR = 5.38; 95% CI, 1.53 to 18.96), 
about four times likely to have a poor functional status on discharge ( BI < 45, OR = 4.40; 95% CI, 1.45 to 
13.35) and twice as likely to die from stroke within 30 days of admission (OR = 2.19; 95% CI, 0.72 to 6.65). 
Urinary tract infection (UTI) was commoner in women (P = 0.023), with no major difference in other stroke 
complications (Figure 2). There was no sex difference in duration of in-hospital stay. (P = 0.168) Table 3, 
shows the summary of significant differences. 
DISCUSSIONS 
These data provide an evidence of differences by sex of stroke presentation and outcomes. 
This study shows that women were less likely to be educated, to smoke or to take alcohol. Women were 
however more likely to present in coma, and have to a more severe stroke at presentation. Women were 
also more likely to be disabled and to be handicapped on discharge. Despite the higher likelihood of men 
receiving antihypertensive medications prestroke, they still had a higher DBP on admission. This may be a 
reflection of the general lack of optimal BP control among hypertensives in the African subregion (7, 31). 
Although, there was no sex difference in hypertension as a risk factor in this study; studies have shown that 
women were more likely to be hypertensive, (22, 2, 51) though this may not be so in black Africans with 
stroke. In the study by Andersen et al (2), they reported that hypertension was slightly more prevalent in men 
below the age of 50 years, after which the prevalence increased in women. Since our patients are younger 
we may not have similar findings. 
We found no significant difference in risk factors such as DM, TIA and AF. Findings from other studies 
showed that women were more likely to have hypertension and AF (8, 13, 38, 11, 16), while men were more 
likely to have DM and heart disease (11, 16). Our finding of more frequent alcohol intake and smoking 
concurs with reports from other studies (8, 13, 11). 
Our study showed that men were more likely to be on antihypertensives prestroke, and no sex difference in 
the use of lipid lowering, antiplatelets or antidiabetic medications. Our observation is divergent to the studies 
showing that women were more likely to have treatment of high blood pressure prestroke (31, 9). The study 
by Smith et al (44) showed that women were more likely to be treated with antihypertensives, and less likely 
to receive antidiabetic, antithrombotic and lipid-lowering medications during the course of stroke treatment. 
The study by Khan et al, (22) is also in agreement that women were more likely to receive antihypertensive 
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after a stroke. Report by Bushnell et al (6) on the use of statins showed that there was no sex difference in 
the use of statins or any statistical interaction between the effects of sex and statin use on the risk of stroke. 
In our study lacunar strokes were commoner in men; this is congruent with a study by Foster et al (10) and 
divergent to some studies that reported lacunar strokes occurring more frequently in women with TACS. (44, 
39, 35) 
Women were reported to be older in several studies, (45, 13, 10, 44, 11) but this is not so in our study. The 
Framingham study (35) observed that women developed stroke an average of 5 years later than men. This 
difference in our study may be due to the relatively younger age of our cohort, smaller number of women 
participants and women in our community are less likely to seek medical attention early due to 
socioeconomic reasons, this may influence poorer outcomes and not reach the hospital alive. (32, 20, 49) 
The women in this study were less likely to be educated compared to men; it has been shown that level of 
education influences socioeconomic status. A lower socioeconomic status not only increases the likelihood 
of having a stroke (20), but also impacts negatively on stroke presentation and care. (52) 
Although other reports have shown no differences in stroke severity and case fatality rate (10, 17, 35); this 
study is in agreement with studies done elsewhere indicating that women were more likely have a severe 
stroke on admission and have worse outcomes after stroke, women were more likely to be disabled and 
handicapped on discharge, less likely to achieve activities of daily living independence and have a poorer 
quality of life. (8, 39, 43, 12, 24, 15) An excess of lacunar strokes in this study may contribute to the better 
outcome in men compared to women. A study by Sacco et al (41) observed that patients with lacunar stroke 
have a better outcome compared to those with nonlacunar strokes. 
In keeping with a more severe stroke women were more likely to be comatose at presentation compared to 
men, as reported by Gall et al (11). Gargano et al (14) showed no sex difference in patients presenting with 
coma, but asserted that delay in presentation to the emergency room may explain some of the differences in 
symptoms. 
Our study showed that women were twice as likely to die within thirty days from a stroke. This is consistent 
with some reports, (38, 11) but at variance with other studies. (8, 13, 10, 19) There are other studies that 
have shown lower rates of mortality in younger women than men and higher number in older women where 
the absolute burden of stroke is greater (24, 4). The higher mortality in women in other studies, were 
attributed to increasing age, a higher stroke severity and lower quality of care in women compared with men. 
(38, 4) There was no significant difference in the duration of hospital admission; this is congruent with a 
study by Zhu et al (53) who reported no sex difference in length of hospital stay. In our study UTI was 
commoner in women, and is in accordance with other studies. (13, 39) 
Studies have shown that women were less likely to be investigated or treated with thrombolytics, (8, 13, 39, 
47), but it is not universal. It is interesting to note from studies by Kent et al (21) and Sacco et al (40) that 
women were more likely to benefit from thrombolytic therapy. This may be an area of further research in our 
environment. Gargano et al (13) in their study explaining why women were less likely to be treated argued 
that women were older than men and this influences management owing to comorbid conditions. Women are 
less likely to have surgical interventions like carotid endarterectomy. (34) A study by Tell et al (46) observed 
that men were more likely to have carotid atherosclerotic disease than women, and may explain why men 
have higher endarterectomies. 
Studies have postulated why women are likely to have severe stroke; Women brains are more likely to 
produce a stronger and more sustained inflammatory response compared to that of men in animal studies, 
consistent with increased immune responses (25, 27). In an experimental study with rats reported that 
oestrogen offers some neuroprotection in neuronal injury and this may be lost as women become older, (28) 
others have postulated the role of parity and increasing parity with increased mortality from both Ischaemic 
and haemorrhaghic stroke. (30, 18, 23) The main strength is the prospective nature of the study, regular 
follow-ups and various scoring systems used for stroke severity and disability. 
The small sample size is a limitation of this study. We did not consider sex differences in recognition of 
stroke symptoms; as this may influence presentation and subsequent care. We also did not consider sex 
related effect of stroke care. 




This study reveals sex differences in stroke presentation and outcome among Nigerians. After adjusting for 
cofounding variables we observed that women have more severe stroke on admission, and were more likely 
to be disabled and handicapped on discharge. In keeping with a severe stroke, they were more likely to be in 
coma on admission. Women were twice more likely to die from a stroke. 
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Figure 1. Inclusion and exclusion criteria, diagnosis and type of stroke. (48) 
 
 





Figure 2. Stroke complications. Stacked bars are percentages of subjects with complications 
comparing sex groups. Asterisk * indicates P < 0.05. 
 
TABLE 1. COMPARISON OF DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF SUBJECTS BY 
SEX 
 
Women  Men  P-value  
Demographic characteristic 
Total 30 (33%) 61(67%) 0.004* 
Mean age 55.6±12.4 56.2±11.1 0.823 
Median age 55 (35-80) 57 (24-80) 
 
Formal Education † 4 (8.8%) 31 (33.18%) 0.024* 
Stroke type 
Haemorrhagic 5 (16.7%) 13 (21.3%) 0.812 
Ischaemic 25 (83.3%) 48 (78.7%) 0.812 
Clinical syndrome of Ischaemic stroke 
TASC 8 (32.0%) 14 (29.2%) 0.976 
PASC 15 (60.0%) 25 (52.1%) 0.626 
POSC 1 (4.0%) 2 (4.2%) 1.000 
Lacunar 1 (4.0%) 7 (14.6%) 0.048* 




Women  Men  P-value  
Risk profile 
Hypertension 25 (83.3%) 49 (80.3%) 0.953 
Diabetes 2 (6.7%) 3 (4.9%) 1.000 
TIA 2 (6.7%) 5 (8.2%) 1.000 
Smoking 0 (0.0%) 10 (16.4) 0.046* 
Alcohol 1(3.3%) 15 (24.6%) 0.027* 
HIV 1 (3.3%) 3 (4.9%) 1.000 
Atrial fibrillation 2 (6.7%) 1 (1.6%) 0.511 
Antiphospholipid syndrome 1 (3.3%) 0 (0.0%) 0.725 
Heart failure 1 (3.3%) 1 (1.6%) 1.000 
Prestroke medications 
Antihypertensive 3 (10%) 20 (32.8%) 0.036* 
Antiplatelet 3 (10%) 9 (14.8%) 0.759 
Lipid lowering agent 1 (3.3%) 3 (4.9%) 1.000 
Diabetic medication 1 (3.3%) 2 (3.2%) 1.000 
Clinical state at time of presentation 
Coma 9 (30.0%) 3 (4.9%) 0.003* 
Mean SBP 148.5 ± 29.1 158.1 ± 37.9 0.225 
(min-max) (110-220) (90-250) 
 
Mean DBP 90.5±18.3 100.1±22.6 0.046* 
(min-max) (60-130) (40-150) 
 
Mean admission Random glucose 6.3±2.5 6.1±2.7 0.772 
Duration of in-hospital stay (days) 43.0±33.1 33.9± 27.3 0.168 
30-Day fatality 9 (30.0%) 9 (14.8%) 0.175 
TACS - total anterior circulation stroke, 
PACS - partial anterior circulation stroke, 
POCS - posterior circulation stroke, 
TIA - transient ischaemic attack. 
SBP - systolic blood pressure, 
DBP - diastolic blood pressure. 
NIHSS - national institutes of health stroke scale. 
* P - value < 0.05 from student’s t - test. 
† - At least a secondary school education 
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TABLE 2: INDEPENDENT PREDICTORS OF STROKE SEVERITY, DISABILITY AND 30-DAY 
MORTALITY AMONG FEMALE SEX. 
Independent variable OR 95% CI 
Admission Barthel’s ADL < 45 5.30 (1.10 - 25.62)* 
Admission mRS > 4 5.38 (1.53 - 18.96 * 
Discharge Barthel’s ADL > 90 0.99 (0.31 - 3.20) 
Discharge Barthel’s ADL < 45 4.40 (1.45 - 13.35)* 
30-Day fatality 2.19 (0.72 - 6.65) 
Logistic regression analysis of variables, * P < 0.05 
Table 3. Summary of significant differences 
Women>Men Men>Women 
Less likely to be Educated Smoking 
Coma on admission Alcohol 
Severe stroke on admission Hypertensive medication prestroke 
Poor functional status on discharge Lacunar strokes 
Urinary Tract Infection Higher diastolic BP on admission 
More likely to die within 30 days 
 
NIHSS - National Institutes of Health Stroke Scale. 
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